Pictet Asset Management Holding Sa Moon Lake Immunotherapeutics Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 322,114 shares of MLTX stock, worth $12.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
322,114
Previous 346,617
7.07%
Holding current value
$12.6 Million
Previous $18.4 Million
31.68%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding MLTX
# of Institutions
161Shares Held
55.3MCall Options Held
481KPut Options Held
229K-
Bvf Inc San Francisco, CA19.8MShares$770 Million33.91% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$331 Million35.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.97MShares$116 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$108 Million1.75% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.48MShares$57.7 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.44B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...